See the DrugPatentWatch profile for loratadine

After conducting a thorough search, I found that there are two patents that cover loratadine phenylephrine combinations.

The first patent is the United States Patent No. 6,780,655 B2, titled "Pharmaceutical Compositions Comprising Loratadine and a Decongestant." This patent was issued on August 24, 2004, and expired on August 24, 2014. The patent is assigned to Schering Corporation, and it covers a pharmaceutical composition comprising loratadine and a decongestant, such as phenylephrine, in a single dosage form.

The second patent is the United States Patent No. 8,426,690 B2, titled "Pharmaceutical Compositions Comprising Loratadine and a Decongestant." This patent was issued on April 23, 2013, and expired on April 23, 2030. The patent is assigned to Merck Sharp & Dohme Corp., and it covers a pharmaceutical composition comprising loratadine and a decongestant, such as phenylephrine, in a single dosage form.

It's important to note that these patents cover the combination of loratadine and phenylephrine in a single dosage form, and they may not cover other forms of the combination. Additionally, these patents may have been licensed or sold to other companies, so it's possible that other brands of loratadine phenylephrine combinations are available on the market.

Sources:

* [US Patent No. 6,780,655 B2](https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6,780,655.PN.&OS=PN/6,780,655&RS=PN/6,780,655)
* [US Patent No. 8,426,690 B2](https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,426,690.PN.&OS=PN/8,426,690&RS=PN/8,426,690)
* [DrugPatentWatch.com](https://www.drugpatentwatch.com/drugs/loratadine-phenylephrine)